These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8742419)

  • 41. Synthesis and binding properties of 2-amino-5-phosphono-3-pentenoic acid photoaffinity ligands as probes for the glutamate recognition site of the NMDA receptor.
    Heckendorn R; Allgeier H; Baud J; Gunzenhauser W; Angst C
    J Med Chem; 1993 Nov; 36(23):3721-6. PubMed ID: 7902441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunochemical and immunohistochemical characterization of a synaptic membrane protein that binds the competitive antagonists of NMDA receptors.
    Eggeman KT; Pal R; Walsh J; Kumar KN; Michaelis EK
    Neurosci Lett; 1993 Aug; 158(2):173-6. PubMed ID: 7901820
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery and synthesis of a novel and selective drug-like P2X(1) antagonist.
    Jaime-Figueroa S; Greenhouse R; Padilla F; Dillon MP; Gever JR; Ford AP
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3292-5. PubMed ID: 15927468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in the ADP-ribosylation status of some hippocampal proteins are linked to kindling progression.
    Vezzani A; Sparvoli S; Rizzi M; Zinetti M; Fratelli M
    Neuroreport; 1994 Jun; 5(10):1217-20. PubMed ID: 7919168
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and brain regional distribution of [11C]NPS 1506 in mice and rat: an N-methyl-D-aspartate (NMDA) receptor antagonist.
    Fuchigami T; Haradahira T; Arai T; Okauchi T; Maeda J; Suzuki K; Yamamoto F; Suhara T; Sasaki S; Maeda M
    Biol Pharm Bull; 2003 Nov; 26(11):1570-3. PubMed ID: 14600403
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of suramin on neuroendocrine and behavioural responses to conditioned fear stimuli.
    Zou CJ; Onaka TO; Yagi K
    Neuroreport; 1998 Apr; 9(6):997-9. PubMed ID: 9601656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nucleotide radiolabels as tools for studying P2Y receptors in membranes from brain and lung tissue.
    Reiser G; Laubinger W; Schäfer R
    Prog Brain Res; 1999; 120():45-58. PubMed ID: 10550987
    [No Abstract]   [Full Text] [Related]  

  • 48. An attachment of protamines to cerebral tissues, studied in relation to gangliosides, suramin and tissue excitability.
    THOMSON CG; McILWAIN H
    Biochem J; 1961 May; 79(2):342-7. PubMed ID: 13776646
    [No Abstract]   [Full Text] [Related]  

  • 49. [Visualization of tissue immune reactions].
    JANCSO N; JANCSO-GABOR A
    Acta Physiol Acad Sci Hung; 1952; 3(3-4):555-62. PubMed ID: 13065126
    [No Abstract]   [Full Text] [Related]  

  • 50. [Cellular partition and storage mechanism of Bayer 205 (Germanin) in the tissues].
    JANCSO N; JANCSO-GABOR A
    Acta Physiol Acad Sci Hung; 1952; 3(3-4):537-54. PubMed ID: 13065125
    [No Abstract]   [Full Text] [Related]  

  • 51. Synaptic control of motoneuronal excitability.
    Rekling JC; Funk GD; Bayliss DA; Dong XW; Feldman JL
    Physiol Rev; 2000 Apr; 80(2):767-852. PubMed ID: 10747207
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ATP as a mediator of mammalian central CO2 chemoreception.
    Thomas T; Spyer KM
    J Physiol; 2000 Mar; 523 Pt 2(Pt 2):441-7. PubMed ID: 10699087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional characterization of the P2X(4) receptor orthologues.
    Jones CA; Chessell IP; Simon J; Barnard EA; Miller KJ; Michel AD; Humphrey PP
    Br J Pharmacol; 2000 Jan; 129(2):388-94. PubMed ID: 10694247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of [3H]CGP 39653 binding to NMDA receptors by a P2 antagonist, suramin.
    Balcar VJ; Dias LS; Li Y; Bennett MR
    Neuroreport; 1995 Dec; 7(1):69-72. PubMed ID: 8742419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
    Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG
    Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methionine sulfoximine shows excitotoxic actions in rat cortical slices.
    Shaw CA; Bains JS; Pasqualotto BA; Curry K
    Can J Physiol Pharmacol; 1999 Nov; 77(11):871-7. PubMed ID: 10593660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites.
    Christie JM; Jane DE; Monaghan DT
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1169-74. PubMed ID: 10688637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. P2 purinoceptor blocker suramin antagonises NMDA receptors and protects against excitatory behaviour caused by NMDA receptor agonist (RS)-(tetrazol-5-yl)-glycine in rats.
    Ong WY; Motin LG; Hansen MA; Dias LS; Ayrout C; Bennett MR; Balcar VJ
    J Neurosci Res; 1997 Sep; 49(5):627-38. PubMed ID: 9302084
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Experimental approaches to perceptual dysfunction in schizophrenia].
    Gargiulo PA
    Rev Neurol; 2003 Sep 16-30; 37(6):545-51. PubMed ID: 14533075
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.